

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | oligosaccharide biosynthetic process (GO:0009312) | 8.95213421 |
| 2 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 8.57666185 |
| 3 | positive regulation of p38MAPK cascade (GO:1900745) | 8.13395151 |
| 4 | pattern specification involved in kidney development (GO:0061004) | 7.03572554 |
| 5 | oligosaccharide catabolic process (GO:0009313) | 6.50431335 |
| 6 | glycosphingolipid catabolic process (GO:0046479) | 6.28187525 |
| 7 | positive regulation of bone resorption (GO:0045780) | 6.07742983 |
| 8 | positive regulation of bone remodeling (GO:0046852) | 6.07742983 |
| 9 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 6.04019635 |
| 10 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 6.02960871 |
| 11 | glycolipid catabolic process (GO:0019377) | 5.77294758 |
| 12 | amino sugar catabolic process (GO:0046348) | 5.68496902 |
| 13 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 5.58838158 |
| 14 | glucosamine-containing compound catabolic process (GO:1901072) | 5.45298132 |
| 15 | linoleic acid metabolic process (GO:0043651) | 5.38878644 |
| 16 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 5.36388410 |
| 17 | N-acetylneuraminate metabolic process (GO:0006054) | 5.19439502 |
| 18 | detection of molecule of bacterial origin (GO:0032490) | 5.16577536 |
| 19 | osteoclast differentiation (GO:0030316) | 5.07758353 |
| 20 | regulation of p38MAPK cascade (GO:1900744) | 5.01193148 |
| 21 | interferon-gamma secretion (GO:0072643) | 4.94371256 |
| 22 | cellular extravasation (GO:0045123) | 4.94055023 |
| 23 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.90784670 |
| 24 | regulation of monocyte differentiation (GO:0045655) | 4.90240775 |
| 25 | nephron epithelium morphogenesis (GO:0072088) | 4.68020331 |
| 26 | nephron tubule morphogenesis (GO:0072078) | 4.68020331 |
| 27 | lactation (GO:0007595) | 4.65775599 |
| 28 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 4.59422142 |
| 29 | ectoderm development (GO:0007398) | 4.55890307 |
| 30 | regulation of sequestering of triglyceride (GO:0010889) | 4.51299522 |
| 31 | superoxide anion generation (GO:0042554) | 4.46390403 |
| 32 | pinocytosis (GO:0006907) | 4.43869820 |
| 33 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.32868047 |
| 34 | regulation of cholesterol storage (GO:0010885) | 4.31645703 |
| 35 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.30978257 |
| 36 | mammary gland epithelial cell differentiation (GO:0060644) | 4.24796860 |
| 37 | positive regulation of tissue remodeling (GO:0034105) | 4.23685677 |
| 38 | negative regulation of execution phase of apoptosis (GO:1900118) | 4.19346742 |
| 39 | lung epithelium development (GO:0060428) | 4.18687604 |
| 40 | sphingolipid catabolic process (GO:0030149) | 4.17563193 |
| 41 | keratinocyte development (GO:0003334) | 4.17453728 |
| 42 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.16346347 |
| 43 | acyl-CoA biosynthetic process (GO:0071616) | 4.12556244 |
| 44 | thioester biosynthetic process (GO:0035384) | 4.12556244 |
| 45 | membrane lipid catabolic process (GO:0046466) | 4.11361755 |
| 46 | regulation of transforming growth factor beta1 production (GO:0032908) | 4.09110737 |
| 47 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 4.08796690 |
| 48 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.06010997 |
| 49 | neutrophil activation involved in immune response (GO:0002283) | 4.05826962 |
| 50 | transferrin transport (GO:0033572) | 3.99086434 |
| 51 | secretion by tissue (GO:0032941) | 3.98375504 |
| 52 | replicative senescence (GO:0090399) | 3.97595150 |
| 53 | keratinization (GO:0031424) | 3.97108075 |
| 54 | phagosome maturation (GO:0090382) | 3.96392621 |
| 55 | peptide catabolic process (GO:0043171) | 3.94281472 |
| 56 | folic acid transport (GO:0015884) | 3.92703689 |
| 57 | DNA damage induced protein phosphorylation (GO:0006975) | 3.92416062 |
| 58 | renal tubule morphogenesis (GO:0061333) | 3.90231811 |
| 59 | apoptotic cell clearance (GO:0043277) | 3.88746030 |
| 60 | copper ion transport (GO:0006825) | 3.85758323 |
| 61 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.81880795 |
| 62 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.80214222 |
| 63 | iron ion import (GO:0097286) | 3.73881680 |
| 64 | ferric iron transport (GO:0015682) | 3.73215079 |
| 65 | trivalent inorganic cation transport (GO:0072512) | 3.73215079 |
| 66 | ceramide catabolic process (GO:0046514) | 3.70369708 |
| 67 | biotin metabolic process (GO:0006768) | 3.68954613 |
| 68 | oligosaccharide metabolic process (GO:0009311) | 3.67903250 |
| 69 | O-glycan processing (GO:0016266) | 3.65958777 |
| 70 | carnitine shuttle (GO:0006853) | 3.65166209 |
| 71 | response to peptidoglycan (GO:0032494) | 3.63296517 |
| 72 | eosinophil migration (GO:0072677) | 3.62531875 |
| 73 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.60553887 |
| 74 | eosinophil chemotaxis (GO:0048245) | 3.53574454 |
| 75 | response to host immune response (GO:0052572) | 3.52787414 |
| 76 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.52787414 |
| 77 | regulation of endothelial cell differentiation (GO:0045601) | 3.49766947 |
| 78 | decidualization (GO:0046697) | 3.49550692 |
| 79 | detection of external biotic stimulus (GO:0098581) | 3.44255789 |
| 80 | response to host (GO:0075136) | 3.42343316 |
| 81 | response to host defenses (GO:0052200) | 3.42343316 |
| 82 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.42343316 |
| 83 | body fluid secretion (GO:0007589) | 3.39794560 |
| 84 | myeloid dendritic cell differentiation (GO:0043011) | 3.38946488 |
| 85 | fatty acid transmembrane transport (GO:1902001) | 3.37158046 |
| 86 | segment specification (GO:0007379) | 3.35401718 |
| 87 | metanephric nephron tubule development (GO:0072234) | 3.32807795 |
| 88 | metanephric tubule development (GO:0072170) | 3.32807795 |
| 89 | positive regulation of osteoclast differentiation (GO:0045672) | 3.32712237 |
| 90 | cell differentiation involved in metanephros development (GO:0072202) | 3.32190394 |
| 91 | response to thyroid hormone (GO:0097066) | 3.32045448 |
| 92 | desmosome organization (GO:0002934) | 3.28617390 |
| 93 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.24929814 |
| 94 | positive regulation of leukocyte degranulation (GO:0043302) | 3.24876836 |
| 95 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.23816881 |
| 96 | positive regulation by symbiont of host defense response (GO:0052509) | 3.20864926 |
| 97 | modulation by symbiont of host defense response (GO:0052031) | 3.20864926 |
| 98 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.20864926 |
| 99 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.20864926 |
| 100 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.20864926 |
| 101 | modulation by symbiont of host immune response (GO:0052553) | 3.20864926 |
| 102 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.20256320 |
| 103 | detection of other organism (GO:0098543) | 3.18701868 |
| 104 | barbed-end actin filament capping (GO:0051016) | 3.17514446 |
| 105 | collecting duct development (GO:0072044) | 3.14733321 |
| 106 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.12227310 |
| 107 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.12227310 |
| 108 | hepatocyte differentiation (GO:0070365) | 3.12147200 |
| 109 | positive regulation of mast cell activation (GO:0033005) | 3.11683817 |
| 110 | regulation of cholesterol homeostasis (GO:2000188) | 3.11627316 |
| 111 | lipid storage (GO:0019915) | 3.11562303 |
| 112 | positive regulation of mast cell degranulation (GO:0043306) | 3.11430609 |
| 113 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.11430609 |
| 114 | mitochondrial calcium ion transport (GO:0006851) | 3.07857052 |
| 115 | establishment of skin barrier (GO:0061436) | 3.06532424 |
| 116 | regulation of water loss via skin (GO:0033561) | 3.05859468 |
| 117 | activation of MAPKKK activity (GO:0000185) | 3.04587840 |
| 118 | sphingosine metabolic process (GO:0006670) | 3.03239559 |
| 119 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.02967702 |
| 120 | pH reduction (GO:0045851) | 3.02667311 |
| 121 | regulation of mononuclear cell migration (GO:0071675) | 3.02025615 |
| 122 | neural tube formation (GO:0001841) | 3.02011257 |
| 123 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.01957076 |
| 124 | metanephric nephron epithelium development (GO:0072243) | 3.01674644 |
| 125 | intracellular pH reduction (GO:0051452) | 3.00931564 |
| 126 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.00369686 |
| 127 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.00369686 |
| 128 | regulation of bone resorption (GO:0045124) | 2.99150122 |
| 129 | phosphate ion homeostasis (GO:0055062) | 2.98415062 |
| 130 | trivalent inorganic anion homeostasis (GO:0072506) | 2.98415062 |
| 131 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.97798446 |
| 132 | hemidesmosome assembly (GO:0031581) | 2.97637993 |
| 133 | negative regulation of lipid storage (GO:0010888) | 2.96911531 |
| 134 | regulation of penile erection (GO:0060405) | 2.96740947 |
| 135 | response to progesterone (GO:0032570) | 2.96616635 |
| 136 | iron ion transport (GO:0006826) | 2.95514063 |
| 137 | chronic inflammatory response (GO:0002544) | 2.95450385 |
| 138 | tooth mineralization (GO:0034505) | 2.95199828 |
| 139 | cellular anion homeostasis (GO:0030002) | 2.94886111 |
| 140 | positive regulation of receptor recycling (GO:0001921) | 2.94341500 |
| 141 | vitamin D metabolic process (GO:0042359) | 2.93934950 |
| 142 | facial nerve structural organization (GO:0021612) | 2.93571582 |
| 143 | regulation of mast cell degranulation (GO:0043304) | 2.93110583 |
| 144 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.92892575 |
| 145 | transcytosis (GO:0045056) | 2.92158057 |
| 146 | regulation of monocyte chemotaxis (GO:0090025) | 2.90852698 |
| 147 | response to magnesium ion (GO:0032026) | 2.89644073 |
| 148 | myeloid dendritic cell activation (GO:0001773) | 2.89203776 |
| 149 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.88163096 |
| 150 | polyol transport (GO:0015791) | 2.84480095 |
| 151 | lipoxygenase pathway (GO:0019372) | 2.82832871 |
| 152 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.82336278 |
| 153 | positive regulation of cholesterol efflux (GO:0010875) | 2.81364345 |
| 154 | negative regulation of interleukin-12 production (GO:0032695) | 2.80816392 |
| 155 | regulation of mitotic spindle organization (GO:0060236) | 2.80709458 |
| 156 | metanephric epithelium development (GO:0072207) | 2.80042819 |
| 157 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.78879952 |
| 158 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.78455546 |
| 159 | detection of bacterium (GO:0016045) | 2.77828712 |
| 160 | growth hormone receptor signaling pathway (GO:0060396) | 2.77500762 |
| 161 | regulation of leukocyte degranulation (GO:0043300) | 2.76239847 |
| 162 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.75767321 |
| 163 | detection of biotic stimulus (GO:0009595) | 2.75470924 |
| 164 | * pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.73770026 |
| 165 | keratan sulfate catabolic process (GO:0042340) | 2.73092287 |
| 166 | otic vesicle formation (GO:0030916) | 2.72515630 |
| 167 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.72421821 |
| 168 | diol metabolic process (GO:0034311) | 2.71922751 |
| 169 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.71236646 |
| 170 | granulocyte activation (GO:0036230) | 2.70728994 |
| 171 | regulation of mast cell activation (GO:0033003) | 2.70187187 |
| 172 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.69977421 |
| 173 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.69654218 |
| 174 | ganglioside metabolic process (GO:0001573) | 2.69541763 |
| 175 | phagocytosis, recognition (GO:0006910) | 2.69529158 |
| 176 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.69374108 |
| 177 | embryonic process involved in female pregnancy (GO:0060136) | 2.68740954 |
| 178 | regulation of macrophage chemotaxis (GO:0010758) | 2.68061010 |
| 179 | carnitine transmembrane transport (GO:1902603) | 2.67250719 |
| 180 | granulocyte chemotaxis (GO:0071621) | 2.66385577 |
| 181 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.66277647 |
| 182 | granulocyte migration (GO:0097530) | 2.63328708 |
| 183 | positive regulation of odontogenesis (GO:0042482) | 2.62203455 |
| 184 | neutrophil chemotaxis (GO:0030593) | 2.62190791 |
| 185 | regulation of hypersensitivity (GO:0002883) | 2.62083710 |
| 186 | protein localization to endosome (GO:0036010) | 2.61018042 |
| 187 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.60888045 |
| 188 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.60887402 |
| 189 | regulation of intracellular pH (GO:0051453) | 2.58572710 |
| 190 | respiratory burst (GO:0045730) | 2.57003749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 6.84747261 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.96968795 |
| 3 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 4.77775201 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.61009547 |
| 5 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.54117767 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.48567353 |
| 7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.23379168 |
| 8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 3.20142823 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15128176 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.00790170 |
| 11 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.81839820 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74713041 |
| 13 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.46818996 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.25390337 |
| 15 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.15081038 |
| 16 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.13172318 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.06051116 |
| 18 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.03710387 |
| 19 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.01230954 |
| 20 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.93996943 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.92465576 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.85052325 |
| 23 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84699904 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.84192430 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.82619684 |
| 26 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.82526276 |
| 27 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.77584319 |
| 28 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.72396678 |
| 29 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.71521671 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.64761597 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.63429294 |
| 32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.62768020 |
| 33 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.61857159 |
| 34 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.61615147 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60694087 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58995517 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58384460 |
| 38 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.57048132 |
| 39 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.55610967 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.55297933 |
| 41 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54037911 |
| 42 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.53804551 |
| 43 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.53448371 |
| 44 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.49948695 |
| 45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.48204250 |
| 46 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.48109917 |
| 47 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.45794757 |
| 48 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.44695170 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44284165 |
| 50 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.43357130 |
| 51 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.42319924 |
| 52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.41245044 |
| 53 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.40671850 |
| 54 | CJUN_26792858_Chip-Seq_BT549_Human | 1.40098958 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39702708 |
| 56 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.39227750 |
| 57 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.37146336 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36631071 |
| 59 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.35524048 |
| 60 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35407654 |
| 61 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.34433104 |
| 62 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.34012168 |
| 63 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.32822271 |
| 64 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.32601015 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30938710 |
| 66 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.29466773 |
| 67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.28406378 |
| 68 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.27973997 |
| 69 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.27973997 |
| 70 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26354149 |
| 71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25826762 |
| 72 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.25688179 |
| 73 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.25535276 |
| 74 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25159711 |
| 75 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.25094883 |
| 76 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.24188793 |
| 77 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.23699980 |
| 78 | RXR_22108803_ChIP-Seq_LS180_Human | 1.23592809 |
| 79 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22779293 |
| 80 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.21847249 |
| 81 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.21060393 |
| 82 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.19475151 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.18755018 |
| 84 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.18654587 |
| 85 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.17855848 |
| 86 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.17796948 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.17545603 |
| 88 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17436790 |
| 89 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17256899 |
| 90 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16975924 |
| 91 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.16814675 |
| 92 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.16612695 |
| 93 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.16097528 |
| 94 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15586971 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14518543 |
| 96 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.14324597 |
| 97 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.14259256 |
| 98 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.12437460 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12345917 |
| 100 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.12327849 |
| 101 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.11902972 |
| 102 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11646538 |
| 103 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.11335325 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11316973 |
| 105 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10954696 |
| 106 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.10760583 |
| 107 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10626916 |
| 108 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10179959 |
| 109 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.10115442 |
| 110 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09695503 |
| 111 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.08247288 |
| 112 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.07632488 |
| 113 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07411395 |
| 114 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07395957 |
| 115 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.06709221 |
| 116 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06445901 |
| 117 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.06409055 |
| 118 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.06034254 |
| 119 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.05470845 |
| 120 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.05408507 |
| 121 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.04902518 |
| 122 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.04283301 |
| 123 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03937523 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02674017 |
| 125 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01893859 |
| 126 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00764010 |
| 127 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00584707 |
| 128 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00425277 |
| 129 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00271388 |
| 130 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.99810871 |
| 131 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99706199 |
| 132 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.99633717 |
| 133 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.99509724 |
| 134 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98931437 |
| 135 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98049507 |
| 136 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97173870 |
| 137 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96794165 |
| 138 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96731267 |
| 139 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.95624652 |
| 140 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95470521 |
| 141 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95335348 |
| 142 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95025379 |
| 143 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94436480 |
| 144 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94276395 |
| 145 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.93864697 |
| 146 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93491420 |
| 147 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.92245439 |
| 148 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91630236 |
| 149 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.89373072 |
| 150 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.88934839 |
| 151 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.88527157 |
| 152 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.87717152 |
| 153 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87333319 |
| 154 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.87266721 |
| 155 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.86821219 |
| 156 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86690923 |
| 157 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86563735 |
| 158 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.86287553 |
| 159 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.85483788 |
| 160 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85306854 |
| 161 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83291961 |
| 162 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.83271038 |
| 163 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83261575 |
| 164 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82151742 |
| 165 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81451951 |
| 166 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.80701865 |
| 167 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80164025 |
| 168 | GATA3_26560356_Chip-Seq_TH2_Human | 0.78034368 |
| 169 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.78034247 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001881_abnormal_mammary_gland | 9.88251611 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 4.30231181 |
| 3 | MP0009840_abnormal_foam_cell | 4.17062434 |
| 4 | MP0003045_fibrosis | 4.01686224 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.58391066 |
| 6 | MP0003136_yellow_coat_color | 3.43727653 |
| 7 | MP0000627_abnormal_mammary_gland | 3.26909531 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.10908149 |
| 9 | MP0003300_gastrointestinal_ulcer | 3.02123454 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.97886024 |
| 11 | MP0000604_amyloidosis | 2.88296842 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.84321106 |
| 13 | MP0001873_stomach_inflammation | 2.77748142 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.76221491 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.61192320 |
| 16 | MP0000566_synostosis | 2.58179807 |
| 17 | MP0002877_abnormal_melanocyte_morpholog | 2.37118739 |
| 18 | MP0002254_reproductive_system_inflammat | 2.35181349 |
| 19 | MP0002168_other_aberrant_phenotype | 2.30979304 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 2.29378919 |
| 21 | MP0006082_CNS_inflammation | 2.27476780 |
| 22 | MP0003950_abnormal_plasma_membrane | 2.27390017 |
| 23 | MP0003329_amyloid_beta_deposits | 2.25334474 |
| 24 | MP0005171_absent_coat_pigmentation | 2.25247002 |
| 25 | MP0003724_increased_susceptibility_to | 2.23408823 |
| 26 | MP0004147_increased_porphyrin_level | 2.13343508 |
| 27 | MP0004264_abnormal_extraembryonic_tissu | 2.13067605 |
| 28 | MP0005395_other_phenotype | 2.07569233 |
| 29 | MP0005365_abnormal_bile_salt | 2.05330975 |
| 30 | MP0005451_abnormal_body_composition | 2.02445027 |
| 31 | MP0005083_abnormal_biliary_tract | 1.98073118 |
| 32 | MP0003436_decreased_susceptibility_to | 1.96397179 |
| 33 | MP0010386_abnormal_urinary_bladder | 1.95528476 |
| 34 | MP0002928_abnormal_bile_duct | 1.93553447 |
| 35 | MP0003303_peritoneal_inflammation | 1.92592770 |
| 36 | MP0002796_impaired_skin_barrier | 1.87697844 |
| 37 | MP0003718_maternal_effect | 1.84291563 |
| 38 | MP0001188_hyperpigmentation | 1.83667876 |
| 39 | MP0000343_altered_response_to | 1.83263833 |
| 40 | MP0002098_abnormal_vibrissa_morphology | 1.80610805 |
| 41 | MP0001853_heart_inflammation | 1.77098578 |
| 42 | MP0003941_abnormal_skin_development | 1.76572812 |
| 43 | MP0003252_abnormal_bile_duct | 1.76226074 |
| 44 | MP0004381_abnormal_hair_follicle | 1.72471327 |
| 45 | MP0010678_abnormal_skin_adnexa | 1.66301279 |
| 46 | MP0001666_abnormal_nutrient_absorption | 1.64139272 |
| 47 | MP0005025_abnormal_response_to | 1.57998402 |
| 48 | MP0005501_abnormal_skin_physiology | 1.50763785 |
| 49 | MP0001790_abnormal_immune_system | 1.50483784 |
| 50 | MP0005387_immune_system_phenotype | 1.50483784 |
| 51 | MP0001664_abnormal_digestion | 1.48421152 |
| 52 | MP0005671_abnormal_response_to | 1.48398699 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.46479799 |
| 54 | MP0000383_abnormal_hair_follicle | 1.44563937 |
| 55 | MP0003828_pulmonary_edema | 1.43037049 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.39700578 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.39700578 |
| 58 | MP0000490_abnormal_crypts_of | 1.35747748 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.33410624 |
| 60 | MP0005220_abnormal_exocrine_pancreas | 1.33341883 |
| 61 | MP0005670_abnormal_white_adipose | 1.31241096 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 1.30636676 |
| 63 | MP0001533_abnormal_skeleton_physiology | 1.29468110 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.26689258 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.25604352 |
| 66 | MP0005000_abnormal_immune_tolerance | 1.24937465 |
| 67 | MP0009278_abnormal_bone_marrow | 1.24324743 |
| 68 | MP0002148_abnormal_hypersensitivity_rea | 1.23772804 |
| 69 | MP0005275_abnormal_skin_tensile | 1.23237755 |
| 70 | MP0003936_abnormal_reproductive_system | 1.22494979 |
| 71 | MP0009764_decreased_sensitivity_to | 1.20124571 |
| 72 | MP0010352_gastrointestinal_tract_polyps | 1.19146862 |
| 73 | MP0002009_preneoplasia | 1.18897602 |
| 74 | MP0004272_abnormal_basement_membrane | 1.16493477 |
| 75 | MP0000377_abnormal_hair_follicle | 1.13510066 |
| 76 | MP0005464_abnormal_platelet_physiology | 1.12672881 |
| 77 | MP0005647_abnormal_sex_gland | 1.10180794 |
| 78 | MP0005257_abnormal_intraocular_pressure | 1.09631962 |
| 79 | MP0003075_altered_response_to | 1.08858946 |
| 80 | MP0008438_abnormal_cutaneous_collagen | 1.06291446 |
| 81 | MP0005023_abnormal_wound_healing | 1.05707826 |
| 82 | MP0002249_abnormal_larynx_morphology | 1.04955951 |
| 83 | MP0002723_abnormal_immune_serum | 1.03490117 |
| 84 | MP0001765_abnormal_ion_homeostasis | 1.02760519 |
| 85 | MP0008260_abnormal_autophagy | 1.02675143 |
| 86 | MP0002420_abnormal_adaptive_immunity | 1.02143292 |
| 87 | MP0000465_gastrointestinal_hemorrhage | 1.01466664 |
| 88 | MP0001177_atelectasis | 1.01003673 |
| 89 | MP0005166_decreased_susceptibility_to | 1.00593020 |
| 90 | MP0004782_abnormal_surfactant_physiolog | 1.00528337 |
| 91 | MP0001819_abnormal_immune_cell | 1.00264083 |
| 92 | MP0001270_distended_abdomen | 0.98639638 |
| 93 | MP0002896_abnormal_bone_mineralization | 0.97270028 |
| 94 | MP0005085_abnormal_gallbladder_physiolo | 0.97099489 |
| 95 | MP0001663_abnormal_digestive_system | 0.96563425 |
| 96 | MP0002060_abnormal_skin_morphology | 0.95337125 |
| 97 | MP0000579_abnormal_nail_morphology | 0.94772203 |
| 98 | MP0003690_abnormal_glial_cell | 0.94069207 |
| 99 | MP0002396_abnormal_hematopoietic_system | 0.93635217 |
| 100 | MP0001800_abnormal_humoral_immune | 0.93473901 |
| 101 | MP0000427_abnormal_hair_cycle | 0.93073248 |
| 102 | MP0004130_abnormal_muscle_cell | 0.92233608 |
| 103 | MP0000647_abnormal_sebaceous_gland | 0.92213890 |
| 104 | MP0001216_abnormal_epidermal_layer | 0.91960403 |
| 105 | MP0002405_respiratory_system_inflammati | 0.91884325 |
| 106 | MP0003878_abnormal_ear_physiology | 0.91640250 |
| 107 | MP0005377_hearing/vestibular/ear_phenot | 0.91640250 |
| 108 | MP0003566_abnormal_cell_adhesion | 0.91391099 |
| 109 | MP0005636_abnormal_mineral_homeostasis | 0.90990809 |
| 110 | MP0004742_abnormal_vestibular_system | 0.90401436 |
| 111 | MP0003453_abnormal_keratinocyte_physiol | 0.88899530 |
| 112 | MP0001851_eye_inflammation | 0.88063304 |
| 113 | MP0002090_abnormal_vision | 0.86733584 |
| 114 | MP0003011_delayed_dark_adaptation | 0.86213580 |
| 115 | MP0005164_abnormal_response_to | 0.85890765 |
| 116 | MP0008469_abnormal_protein_level | 0.85079059 |
| 117 | MP0001727_abnormal_embryo_implantation | 0.84129476 |
| 118 | MP0003279_aneurysm | 0.84003055 |
| 119 | MP0000762_abnormal_tongue_morphology | 0.83101199 |
| 120 | MP0003787_abnormal_imprinting | 0.82065810 |
| 121 | MP0001835_abnormal_antigen_presentation | 0.81546616 |
| 122 | MP0000920_abnormal_myelination | 0.81328267 |
| 123 | MP0003091_abnormal_cell_migration | 0.79503190 |
| 124 | MP0000371_diluted_coat_color | 0.79452296 |
| 125 | MP0005381_digestive/alimentary_phenotyp | 0.79335066 |
| 126 | MP0000685_abnormal_immune_system | 0.78702066 |
| 127 | MP0009384_cardiac_valve_regurgitation | 0.78117668 |
| 128 | MP0005075_abnormal_melanosome_morpholog | 0.77534488 |
| 129 | MP0004510_myositis | 0.77408088 |
| 130 | MP0005319_abnormal_enzyme/_coenzyme | 0.75867805 |
| 131 | MP0001191_abnormal_skin_condition | 0.75759673 |
| 132 | MP0002006_tumorigenesis | 0.74389572 |
| 133 | MP0004947_skin_inflammation | 0.72006584 |
| 134 | MP0009785_altered_susceptibility_to | 0.71671133 |
| 135 | MP0005084_abnormal_gallbladder_morpholo | 0.71409296 |
| 136 | MP0002938_white_spotting | 0.70859613 |
| 137 | MP0000569_abnormal_digit_pigmentation | 0.70525683 |
| 138 | MP0000678_abnormal_parathyroid_gland | 0.70235623 |
| 139 | MP0005310_abnormal_salivary_gland | 0.69682704 |
| 140 | MP0002933_joint_inflammation | 0.69670011 |
| 141 | MP0000015_abnormal_ear_pigmentation | 0.69371137 |
| 142 | MP0010771_integument_phenotype | 0.68981668 |
| 143 | MP0002876_abnormal_thyroid_physiology | 0.67731397 |
| 144 | MP0002419_abnormal_innate_immunity | 0.67168988 |
| 145 | MP0005410_abnormal_fertilization | 0.66727178 |
| 146 | MP0002998_abnormal_bone_remodeling | 0.65531765 |
| 147 | MP0001958_emphysema | 0.65510645 |
| 148 | MP0000003_abnormal_adipose_tissue | 0.65195998 |
| 149 | MP0008004_abnormal_stomach_pH | 0.64304673 |
| 150 | MP0000467_abnormal_esophagus_morphology | 0.63708184 |
| 151 | MP0003448_altered_tumor_morphology | 0.63048510 |
| 152 | MP0001919_abnormal_reproductive_system | 0.62289134 |
| 153 | MP0005375_adipose_tissue_phenotype | 0.62033316 |
| 154 | MP0010155_abnormal_intestine_physiology | 0.61231018 |
| 155 | MP0000462_abnormal_digestive_system | 0.60411236 |
| 156 | MP0002118_abnormal_lipid_homeostasis | 0.60183532 |
| 157 | MP0000470_abnormal_stomach_morphology | 0.59887743 |
| 158 | MP0003795_abnormal_bone_structure | 0.56531793 |
| 159 | MP0003195_calcinosis | 0.56110073 |
| 160 | MP0005334_abnormal_fat_pad | 0.55441144 |
| 161 | MP0001845_abnormal_inflammatory_respons | 0.51648065 |
| 162 | MP0000613_abnormal_salivary_gland | 0.50316014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 8.92169975 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 8.92169975 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 8.92169975 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.45477060 |
| 5 | Stomach cancer (HP:0012126) | 5.16904973 |
| 6 | Amelogenesis imperfecta (HP:0000705) | 4.91235752 |
| 7 | Cystic liver disease (HP:0006706) | 4.63812630 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.63552631 |
| 9 | Neoplasm of the adrenal cortex (HP:0100641) | 4.56516767 |
| 10 | Abnormality of the renal cortex (HP:0011035) | 4.55188766 |
| 11 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.50746775 |
| 12 | Cerebral aneurysm (HP:0004944) | 4.47937942 |
| 13 | Eczematoid dermatitis (HP:0000976) | 4.24801516 |
| 14 | Renal cortical cysts (HP:0000803) | 4.14638851 |
| 15 | Right ventricular cardiomyopathy (HP:0011663) | 4.11122851 |
| 16 | Loss of speech (HP:0002371) | 3.99967552 |
| 17 | Abnormality of renal resorption (HP:0011038) | 3.92127266 |
| 18 | Scanning speech (HP:0002168) | 3.84494813 |
| 19 | Ectropion (HP:0000656) | 3.78848065 |
| 20 | Myocardial infarction (HP:0001658) | 3.67451336 |
| 21 | Dysostosis multiplex (HP:0000943) | 3.63041210 |
| 22 | Tubulointerstitial nephritis (HP:0001970) | 3.59114430 |
| 23 | Aplasia cutis congenita (HP:0001057) | 3.50769550 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 3.47592793 |
| 25 | Disinhibition (HP:0000734) | 3.43591022 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 3.39194230 |
| 27 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.37166496 |
| 28 | White forelock (HP:0002211) | 3.33565091 |
| 29 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.29934230 |
| 30 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.29934230 |
| 31 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.29934230 |
| 32 | Metaphyseal irregularity (HP:0003025) | 3.29207689 |
| 33 | Abnormality of purine metabolism (HP:0004352) | 3.16218065 |
| 34 | Recurrent abscess formation (HP:0002722) | 3.09091505 |
| 35 | Mucopolysacchariduria (HP:0008155) | 3.06182151 |
| 36 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.06182151 |
| 37 | Patchy hypopigmentation of hair (HP:0011365) | 3.04015471 |
| 38 | Bilateral sensorineural hearing impairment (HP:0008619) | 3.01107842 |
| 39 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.98342688 |
| 40 | Malnutrition (HP:0004395) | 2.96563232 |
| 41 | Unilateral renal agenesis (HP:0000122) | 2.92535522 |
| 42 | Tubulointerstitial fibrosis (HP:0005576) | 2.89711939 |
| 43 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.86820465 |
| 44 | Pili torti (HP:0003777) | 2.86182646 |
| 45 | Abnormality of nail color (HP:0100643) | 2.85725859 |
| 46 | Mutism (HP:0002300) | 2.85150773 |
| 47 | Diminished motivation (HP:0000745) | 2.84855326 |
| 48 | Apathy (HP:0000741) | 2.84362158 |
| 49 | Curly hair (HP:0002212) | 2.83716350 |
| 50 | Gout (HP:0001997) | 2.83022370 |
| 51 | Abnormality of the periventricular white matter (HP:0002518) | 2.82282960 |
| 52 | Hypoplasia of dental enamel (HP:0006297) | 2.78424824 |
| 53 | Paralysis (HP:0003470) | 2.75442199 |
| 54 | Atrophic scars (HP:0001075) | 2.74004669 |
| 55 | Onycholysis (HP:0001806) | 2.72658271 |
| 56 | Neurofibrillary tangles (HP:0002185) | 2.72612443 |
| 57 | True hermaphroditism (HP:0010459) | 2.72490400 |
| 58 | Thick nail (HP:0001805) | 2.70313880 |
| 59 | Optic neuritis (HP:0100653) | 2.69754718 |
| 60 | Retrobulbar optic neuritis (HP:0100654) | 2.69754718 |
| 61 | Retinal atrophy (HP:0001105) | 2.67796931 |
| 62 | Abnormality of renal excretion (HP:0011036) | 2.65941557 |
| 63 | Hypoplasia of the iris (HP:0007676) | 2.62727023 |
| 64 | Abnormality of the dental pulp (HP:0006479) | 2.61857494 |
| 65 | Lip pit (HP:0100267) | 2.60309242 |
| 66 | Palmoplantar hyperkeratosis (HP:0000972) | 2.59159220 |
| 67 | Autoimmune thrombocytopenia (HP:0001973) | 2.56849597 |
| 68 | Alopecia of scalp (HP:0002293) | 2.53840096 |
| 69 | Pustule (HP:0200039) | 2.52888253 |
| 70 | Xerostomia (HP:0000217) | 2.51935543 |
| 71 | Pancreatic cysts (HP:0001737) | 2.51221014 |
| 72 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.46586307 |
| 73 | Orchitis (HP:0100796) | 2.46549488 |
| 74 | Cheilitis (HP:0100825) | 2.45631019 |
| 75 | Xanthomatosis (HP:0000991) | 2.43998281 |
| 76 | Glomerulosclerosis (HP:0000096) | 2.43990689 |
| 77 | Cardiovascular calcification (HP:0011915) | 2.42940016 |
| 78 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.40290779 |
| 79 | Palmar hyperkeratosis (HP:0010765) | 2.40089924 |
| 80 | Increased IgE level (HP:0003212) | 2.37827796 |
| 81 | Prolonged neonatal jaundice (HP:0006579) | 2.36935674 |
| 82 | Protuberant abdomen (HP:0001538) | 2.36360612 |
| 83 | Vascular calcification (HP:0004934) | 2.35882714 |
| 84 | Stage 5 chronic kidney disease (HP:0003774) | 2.34747592 |
| 85 | Abnormality of the costochondral junction (HP:0000919) | 2.32809455 |
| 86 | Increased serum ferritin (HP:0003281) | 2.32213680 |
| 87 | Tubular atrophy (HP:0000092) | 2.29772322 |
| 88 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.25611574 |
| 89 | Erythema (HP:0010783) | 2.24766550 |
| 90 | Epidermoid cyst (HP:0200040) | 2.24218553 |
| 91 | Recurrent skin infections (HP:0001581) | 2.23682508 |
| 92 | Abnormality of the nasal septum (HP:0000419) | 2.23551453 |
| 93 | Aortic dissection (HP:0002647) | 2.22269942 |
| 94 | Hyperphosphatemia (HP:0002905) | 2.22114857 |
| 95 | Hepatosplenomegaly (HP:0001433) | 2.20487837 |
| 96 | Milia (HP:0001056) | 2.20166229 |
| 97 | Breast carcinoma (HP:0003002) | 2.19917797 |
| 98 | Abnormality of the renal medulla (HP:0100957) | 2.15786166 |
| 99 | Widely patent fontanelles and sutures (HP:0004492) | 2.15744107 |
| 100 | Nephritis (HP:0000123) | 2.15114651 |
| 101 | Vacuolated lymphocytes (HP:0001922) | 2.14367987 |
| 102 | Plantar hyperkeratosis (HP:0007556) | 2.13994782 |
| 103 | Pancreatic fibrosis (HP:0100732) | 2.12310812 |
| 104 | Abnormality of the axillary hair (HP:0100134) | 2.11811694 |
| 105 | Abnormality of secondary sexual hair (HP:0009888) | 2.11811694 |
| 106 | Subcapsular cataract (HP:0000523) | 2.10990437 |
| 107 | Enlarged epiphyses (HP:0010580) | 2.10413922 |
| 108 | Facial shape deformation (HP:0011334) | 2.10362017 |
| 109 | Potter facies (HP:0002009) | 2.10362017 |
| 110 | Poor head control (HP:0002421) | 2.10289013 |
| 111 | Premature loss of primary teeth (HP:0006323) | 2.09596245 |
| 112 | Bone pain (HP:0002653) | 2.09122756 |
| 113 | Metaphyseal dysplasia (HP:0100255) | 2.08457365 |
| 114 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.08248358 |
| 115 | Keratoconjunctivitis sicca (HP:0001097) | 2.07531542 |
| 116 | Neuronal loss in central nervous system (HP:0002529) | 2.07188205 |
| 117 | Thin bony cortex (HP:0002753) | 2.05521445 |
| 118 | Nausea (HP:0002018) | 2.05445449 |
| 119 | Petechiae (HP:0000967) | 2.04510057 |
| 120 | Tetraparesis (HP:0002273) | 2.02498852 |
| 121 | Overgrowth (HP:0001548) | 2.01241823 |
| 122 | Parakeratosis (HP:0001036) | 2.00935700 |
| 123 | Glucose intolerance (HP:0000833) | 2.00825268 |
| 124 | Azoospermia (HP:0000027) | 2.00327817 |
| 125 | Progressive neurologic deterioration (HP:0002344) | 1.98945158 |
| 126 | Skin nodule (HP:0200036) | 1.98433294 |
| 127 | Tubulointerstitial abnormality (HP:0001969) | 1.98104779 |
| 128 | Aortic aneurysm (HP:0004942) | 1.97903639 |
| 129 | Erythroderma (HP:0001019) | 1.97669439 |
| 130 | Chromsome breakage (HP:0040012) | 1.97521703 |
| 131 | Male infertility (HP:0003251) | 1.95729969 |
| 132 | Abnormality of macrophages (HP:0004311) | 1.95541643 |
| 133 | Purpura (HP:0000979) | 1.94556547 |
| 134 | Steatorrhea (HP:0002570) | 1.93380484 |
| 135 | Abnormality of nucleobase metabolism (HP:0010932) | 1.92978417 |
| 136 | Asymmetric septal hypertrophy (HP:0001670) | 1.92681365 |
| 137 | Axonal loss (HP:0003447) | 1.91989753 |
| 138 | Abnormal trabecular bone morphology (HP:0100671) | 1.91976651 |
| 139 | Generalized aminoaciduria (HP:0002909) | 1.90447330 |
| 140 | Prostate neoplasm (HP:0100787) | 1.90443677 |
| 141 | Congenital, generalized hypertrichosis (HP:0004540) | 1.90005651 |
| 142 | Osteomyelitis (HP:0002754) | 1.89602450 |
| 143 | Upper motor neuron abnormality (HP:0002127) | 1.88327822 |
| 144 | Cerebral inclusion bodies (HP:0100314) | 1.88218011 |
| 145 | Corneal erosion (HP:0200020) | 1.87361157 |
| 146 | Thoracic kyphosis (HP:0002942) | 1.86452483 |
| 147 | Abnormality of dental color (HP:0011073) | 1.85353245 |
| 148 | Myositis (HP:0100614) | 1.84464215 |
| 149 | Abnormal glucose tolerance (HP:0001952) | 1.84407921 |
| 150 | Keratoconjunctivitis (HP:0001096) | 1.82703776 |
| 151 | Hypohidrosis (HP:0000966) | 1.81647273 |
| 152 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.81418954 |
| 153 | Mediastinal lymphadenopathy (HP:0100721) | 1.81405916 |
| 154 | Urticaria (HP:0001025) | 1.80713070 |
| 155 | Dementia (HP:0000726) | 1.80575633 |
| 156 | Neoplasm of the lung (HP:0100526) | 1.80361921 |
| 157 | Esophageal varix (HP:0002040) | 1.80351608 |
| 158 | Gingivitis (HP:0000230) | 1.79718973 |
| 159 | Abnormality of molar morphology (HP:0011070) | 1.79290189 |
| 160 | Abnormality of molar (HP:0011077) | 1.79290189 |
| 161 | Symptomatic seizures (HP:0011145) | 1.79178722 |
| 162 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.78985206 |
| 163 | Hypergonadotropic hypogonadism (HP:0000815) | 1.78580933 |
| 164 | Agnosia (HP:0010524) | 1.78504903 |
| 165 | Abnormality of iron homeostasis (HP:0011031) | 1.77543696 |
| 166 | Periodontitis (HP:0000704) | 1.77318555 |
| 167 | Intrahepatic cholestasis (HP:0001406) | 1.76732752 |
| 168 | Oral leukoplakia (HP:0002745) | 1.76137236 |
| 169 | Aneurysm (HP:0002617) | 1.74869882 |
| 170 | Nephropathy (HP:0000112) | 1.74728738 |
| 171 | Hypophosphatemia (HP:0002148) | 1.74596879 |
| 172 | Long foot (HP:0001833) | 1.73763902 |
| 173 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.73037659 |
| 174 | Abnormality of alanine metabolism (HP:0010916) | 1.73037659 |
| 175 | Hyperalaninemia (HP:0003348) | 1.73037659 |
| 176 | Cone-rod dystrophy (HP:0000548) | 1.71497649 |
| 177 | Hypotrichosis (HP:0001006) | 1.70990432 |
| 178 | Nasolacrimal duct obstruction (HP:0000579) | 1.70401871 |
| 179 | Congenital sensorineural hearing impairment (HP:0008527) | 1.69442141 |
| 180 | Conical tooth (HP:0000698) | 1.67008571 |
| 181 | Absent eyebrow (HP:0002223) | 1.66246871 |
| 182 | Abdominal distention (HP:0003270) | 1.66204396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZAK | 7.26452268 |
| 2 | MAP3K13 | 5.20010735 |
| 3 | SIK1 | 4.77739786 |
| 4 | EPHA2 | 4.33273275 |
| 5 | CAMK1D | 4.00884693 |
| 6 | IRAK3 | 3.61623598 |
| 7 | LATS1 | 2.89657799 |
| 8 | CAMK1G | 2.87137173 |
| 9 | TTK | 2.53242796 |
| 10 | BLK | 2.51785215 |
| 11 | STK24 | 2.47985324 |
| 12 | NME2 | 2.18264584 |
| 13 | STK38L | 2.08849051 |
| 14 | EPHA3 | 2.06865434 |
| 15 | PIK3CA | 2.01648099 |
| 16 | PBK | 2.01348443 |
| 17 | TESK2 | 1.90030591 |
| 18 | GRK7 | 1.86055095 |
| 19 | MATK | 1.86016739 |
| 20 | ACVR1B | 1.76348383 |
| 21 | TAOK3 | 1.65893052 |
| 22 | FGR | 1.58923608 |
| 23 | IRAK4 | 1.44901334 |
| 24 | FRK | 1.44557878 |
| 25 | RIPK4 | 1.38219639 |
| 26 | EIF2AK2 | 1.37588196 |
| 27 | ABL2 | 1.37575508 |
| 28 | PRKG2 | 1.33402117 |
| 29 | STK10 | 1.31511025 |
| 30 | MAP3K9 | 1.29169223 |
| 31 | MAP3K6 | 1.22643887 |
| 32 | IRAK1 | 1.21619183 |
| 33 | PDK2 | 1.18729998 |
| 34 | TYK2 | 1.17285007 |
| 35 | MAP3K14 | 1.17088487 |
| 36 | FER | 1.15569224 |
| 37 | PRKAA2 | 1.13612872 |
| 38 | MYLK | 1.13355492 |
| 39 | STK16 | 1.12450849 |
| 40 | NUAK1 | 1.11204214 |
| 41 | TXK | 1.09431044 |
| 42 | PRKCH | 1.09325576 |
| 43 | TRPM7 | 1.08332363 |
| 44 | STK3 | 1.05219649 |
| 45 | EPHB1 | 1.04252667 |
| 46 | MOS | 1.01733677 |
| 47 | AKT3 | 1.01662221 |
| 48 | STK38 | 1.00085347 |
| 49 | ARAF | 0.99514597 |
| 50 | MAP2K3 | 0.98420793 |
| 51 | MAPK7 | 0.98318079 |
| 52 | KIT | 0.96456759 |
| 53 | NLK | 0.96378428 |
| 54 | CHUK | 0.96277733 |
| 55 | PDK4 | 0.94633606 |
| 56 | PDK3 | 0.94633606 |
| 57 | CDC42BPA | 0.94150870 |
| 58 | TAOK2 | 0.93286951 |
| 59 | TGFBR2 | 0.92832138 |
| 60 | MAPK12 | 0.92721012 |
| 61 | LATS2 | 0.92399813 |
| 62 | TIE1 | 0.90542129 |
| 63 | MAP3K2 | 0.90028174 |
| 64 | NEK6 | 0.89012300 |
| 65 | RIPK1 | 0.88803886 |
| 66 | LIMK1 | 0.88223566 |
| 67 | MAP3K1 | 0.87441123 |
| 68 | MARK3 | 0.86610681 |
| 69 | PTK6 | 0.85930662 |
| 70 | RPS6KB2 | 0.85853023 |
| 71 | PRPF4B | 0.85411896 |
| 72 | ZAP70 | 0.83625607 |
| 73 | PDPK1 | 0.83373288 |
| 74 | INSRR | 0.82095471 |
| 75 | EEF2K | 0.80987138 |
| 76 | JAK3 | 0.80079219 |
| 77 | MAP3K5 | 0.79606981 |
| 78 | FES | 0.78288017 |
| 79 | PIK3CG | 0.74876783 |
| 80 | PLK3 | 0.74367417 |
| 81 | CASK | 0.73932638 |
| 82 | PDGFRB | 0.72951902 |
| 83 | MST4 | 0.72652247 |
| 84 | ADRBK2 | 0.72195242 |
| 85 | MAP3K7 | 0.71894342 |
| 86 | CAMK1 | 0.70321050 |
| 87 | BCKDK | 0.68117140 |
| 88 | MAP3K8 | 0.67931953 |
| 89 | TAOK1 | 0.67873194 |
| 90 | TGFBR1 | 0.66621091 |
| 91 | MET | 0.65081002 |
| 92 | JAK1 | 0.64680483 |
| 93 | LMTK2 | 0.64424390 |
| 94 | PAK4 | 0.63546014 |
| 95 | FGFR4 | 0.62395502 |
| 96 | NEK9 | 0.56401684 |
| 97 | PRKCQ | 0.55854636 |
| 98 | TBK1 | 0.55696004 |
| 99 | MST1R | 0.55569401 |
| 100 | SGK2 | 0.55452477 |
| 101 | DMPK | 0.55215066 |
| 102 | MAPKAPK3 | 0.55182302 |
| 103 | SGK223 | 0.54890757 |
| 104 | SGK494 | 0.54890757 |
| 105 | PDK1 | 0.53679297 |
| 106 | MAP2K6 | 0.51476337 |
| 107 | CSK | 0.51290801 |
| 108 | ICK | 0.51236395 |
| 109 | PRKCE | 0.50834948 |
| 110 | PKN2 | 0.50084554 |
| 111 | GRK1 | 0.47963426 |
| 112 | CDK3 | 0.47003365 |
| 113 | SIK3 | 0.46870484 |
| 114 | TTN | 0.46415832 |
| 115 | LYN | 0.46393465 |
| 116 | SYK | 0.43859183 |
| 117 | STK39 | 0.43314721 |
| 118 | MELK | 0.41795186 |
| 119 | TNK2 | 0.41153418 |
| 120 | IKBKE | 0.40922572 |
| 121 | RPS6KC1 | 0.40193505 |
| 122 | RPS6KL1 | 0.40193505 |
| 123 | PTK2 | 0.39780932 |
| 124 | EGFR | 0.39523670 |
| 125 | CAMKK2 | 0.39343932 |
| 126 | ABL1 | 0.39260775 |
| 127 | PIM1 | 0.38512869 |
| 128 | MAP3K3 | 0.38266401 |
| 129 | PIM2 | 0.38098462 |
| 130 | MAPKAPK2 | 0.36817390 |
| 131 | MAPK15 | 0.36603375 |
| 132 | MAP3K11 | 0.36543709 |
| 133 | TNIK | 0.35723205 |
| 134 | CDK6 | 0.35411711 |
| 135 | PRKAA1 | 0.34556506 |
| 136 | DDR2 | 0.34344920 |
| 137 | CSNK1A1 | 0.34329953 |
| 138 | KSR2 | 0.34194705 |
| 139 | FGFR3 | 0.33595125 |
| 140 | EIF2AK3 | 0.33553382 |
| 141 | PLK4 | 0.32488795 |
| 142 | IRAK2 | 0.32446930 |
| 143 | PRKCD | 0.32143738 |
| 144 | BMPR1B | 0.31495871 |
| 145 | IGF1R | 0.30959430 |
| 146 | GSK3A | 0.30504832 |
| 147 | SGK3 | 0.29674411 |
| 148 | WNK4 | 0.29262110 |
| 149 | RPS6KA2 | 0.28893132 |
| 150 | ERBB3 | 0.28578177 |
| 151 | MAPKAPK5 | 0.27815068 |
| 152 | IKBKB | 0.27734528 |
| 153 | NME1 | 0.26944805 |
| 154 | BMPR2 | 0.26813714 |
| 155 | MKNK2 | 0.26181887 |
| 156 | CHEK2 | 0.24553760 |
| 157 | TEC | 0.24258935 |
| 158 | RPS6KB1 | 0.22796561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 9.13310097 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 7.40712032 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.97798985 |
| 4 | Galactose metabolism_Homo sapiens_hsa00052 | 2.89608854 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.39828200 |
| 6 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.22621408 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.98570989 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.73731488 |
| 9 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.64044243 |
| 10 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.63314624 |
| 11 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.61178527 |
| 12 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.58711317 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.56671246 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.52748470 |
| 15 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.50853907 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.45028959 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.44839279 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.32837080 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.31324455 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.27174758 |
| 21 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.26150409 |
| 22 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.22446584 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.21119073 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10495567 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09095515 |
| 26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.09014311 |
| 27 | Mineral absorption_Homo sapiens_hsa04978 | 1.06810116 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05564349 |
| 29 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.03934204 |
| 30 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.03480409 |
| 31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03371844 |
| 32 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.03161983 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02535852 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.99292641 |
| 35 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.96724355 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.95687791 |
| 37 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.95633377 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.95234834 |
| 39 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93291669 |
| 40 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.91118065 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90449078 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89273455 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 0.88166471 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.86687194 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.84400571 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83269886 |
| 47 | Protein export_Homo sapiens_hsa03060 | 0.78991553 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78233167 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77695235 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 0.77673261 |
| 51 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.77529193 |
| 52 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.76591073 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75869078 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.75083578 |
| 55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.74680725 |
| 56 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.74652958 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.74193289 |
| 58 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.73788691 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.73546539 |
| 60 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72575259 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.72048646 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 0.71199507 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71183373 |
| 64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.70643472 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 0.70569208 |
| 66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69609411 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69262315 |
| 68 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.65280776 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64561861 |
| 70 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.64545031 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.64359325 |
| 72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.64243633 |
| 73 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.64101056 |
| 74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63702474 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61755084 |
| 76 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.59772975 |
| 77 | Adherens junction_Homo sapiens_hsa04520 | 0.59771216 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58786775 |
| 79 | Bladder cancer_Homo sapiens_hsa05219 | 0.57858655 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56802473 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.56360827 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55964242 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | 0.55915542 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55884493 |
| 85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55594640 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54355491 |
| 87 | Measles_Homo sapiens_hsa05162 | 0.52681739 |
| 88 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.52296217 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52215166 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.51681870 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50772825 |
| 92 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49856608 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48951950 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.48420713 |
| 95 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48331670 |
| 96 | Legionellosis_Homo sapiens_hsa05134 | 0.47448989 |
| 97 | Leishmaniasis_Homo sapiens_hsa05140 | 0.46689757 |
| 98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46669891 |
| 99 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.46283417 |
| 100 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46261668 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45399629 |
| 102 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45269251 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.44777465 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.44708848 |
| 105 | Tuberculosis_Homo sapiens_hsa05152 | 0.42064565 |
| 106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41507619 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41454242 |
| 108 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.41329414 |
| 109 | Influenza A_Homo sapiens_hsa05164 | 0.40605806 |
| 110 | Phagosome_Homo sapiens_hsa04145 | 0.40482598 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39439866 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39048474 |
| 113 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38922023 |
| 114 | Malaria_Homo sapiens_hsa05144 | 0.37007556 |
| 115 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.36906191 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36035607 |
| 117 | Histidine metabolism_Homo sapiens_hsa00340 | 0.35032051 |
| 118 | Bile secretion_Homo sapiens_hsa04976 | 0.34795023 |
| 119 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.34094445 |
| 120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33786349 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33476020 |
| 122 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33181752 |
| 123 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32286837 |
| 124 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31984366 |
| 125 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.31170347 |
| 126 | Apoptosis_Homo sapiens_hsa04210 | 0.30943928 |
| 127 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30893556 |
| 128 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.30502114 |
| 129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.30340040 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30052261 |
| 131 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29538676 |
| 132 | Peroxisome_Homo sapiens_hsa04146 | 0.29264267 |
| 133 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.29178557 |
| 134 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28730344 |
| 135 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.28278374 |
| 136 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28025462 |
| 137 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.27945017 |
| 138 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27795790 |
| 139 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.27385681 |
| 140 | Retinol metabolism_Homo sapiens_hsa00830 | 0.26819033 |
| 141 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26473165 |
| 142 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26152438 |
| 143 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.25971256 |
| 144 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.24598889 |
| 145 | Taste transduction_Homo sapiens_hsa04742 | 0.24046997 |
| 146 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23623183 |
| 147 | Hepatitis B_Homo sapiens_hsa05161 | 0.22937445 |
| 148 | Allograft rejection_Homo sapiens_hsa05330 | 0.22859494 |
| 149 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.22075914 |

